<SEC-DOCUMENT>0001640334-23-001425-index.html : 20230802
<SEC-HEADER>0001640334-23-001425.hdr.sgml : 20230802
<ACCEPTANCE-DATETIME>20230802134041
ACCESSION NUMBER:		0001640334-23-001425
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20230802
FILED AS OF DATE:		20230802
DATE AS OF CHANGE:		20230802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NYMOX PHARMACEUTICAL CORP
		CENTRAL INDEX KEY:			0001018735
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12033
		FILM NUMBER:		231134776

	BUSINESS ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
		BUSINESS PHONE:		1-800-936-9669

	MAIL ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>nymox_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
Document 1 - file: nymox_6k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>nymox_ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: nymox_ex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>nymox_ex991img1.jpg
<TEXT>
Document 3 - file: nymox_ex991img1.jpg

</DOCUMENT>
</SEC-DOCUMENT>